Acute administration of vitamin C abrogates protection from ischemic preconditioning in rabbits

Pharmacological Research

Volumn 57, Issue 4, 2008, Pages 283-289

  Tsovolas, Konstantinos ^a   Iliodromitis, Efstathios K ^a   Andreadou, Ioanna ^a,b   Zoga, Anastasia ^a   Demopoulou, Maritina ^b   Iliodromitis, Konstantinos E ^a   Manolaki, Theodora ^a   Markantonis, Sophia L ^b   Kremastinos, Dimitrios Th ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Infarction; Ischemia; Oxygen radicals; Preconditioning; Reperfusion

Indexed keywords

ASCORBIC ACID; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT;

ANIMALS; ASCORBIC ACID; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RABBITS; SUPEROXIDE DISMUTASE;

EID: 43049183577     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.02.003     Document Type: Article

References (42)

1. Kloner R.A., Bolli R., Marban E., Reinlib L., and Braunwald E. Medical and cellular implications of stunning, hibernation and preconditioning. An NHBLI workshop. Circulation 97 (1998) 1848-1867
2. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemia myocardium. Circulation 74 (1986) 1124-1136
3. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83 (2003) 1113-1151
4. Oldenburg O., Qin Q., Krieg T., Yang X.M., Philipp S., Critz S.D., et al. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 286 (2004) H468-H476
5. Schulz R., Cohen M.V., Behrends M., Downey J.M., and Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res 52 (2001) 181-198
6. Tanaka M., Fujiwara H., Yamasaki K., and Sasayama S. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischemic preconditioning in the rabbit. Cardiovasc Res 28 (1994) 980-986
7. Patel H.H., Hsu A., Moore J., and Gross G.J. BW373U86, a δ-opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Mol Cell Cardiol 33 (2001) 1455-1465
8. Constantinou M., Tsantili-Kakoulidou A., Andreadou I., Iliodromitis E.K., Kremastinos DTh, and Mikros E. Application of NMR-based metabonomics in the investigation of myocardial ischemia-reperfusion, ischemic preconditioning and antioxidant intervention in rabbits. Eur J Pharm Sci 30 (2007) 303-314
9. Andreadou I., Iliodromitis E.K., Mikros E., Bofilis E., Zoga A., Constantinou M., et al. Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic Biol Med 37 (2004) 500-510
10. Andreadou I., Iliodromitis E.K., Tsovolas K., Aggeli I.K., Zoga A., Gaitanaki C., et al. Acute administration of vitamin E triggers preconditioning via KATP channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radic Biol Med 41 (2006) 1092-1099
11. Skyschally A., Schulz R., Gres P., Korth H., and Heusch G. Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. Am J Physiol Heart Circ Physiol 284 (2003) H698-H703
12. Jaxa-Chamiec T., Bednarz B., Drozdowska D., Gessek J., Gniot J., Janik K., et al., MIVIT Trial group. Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized double-blind placebo-controlled pilot myocardial infarction and Vitamins trial. Kardiol Pol 62 (2005) 344-350
13. Iliodromitis E., Kremastinos DTh, Katritsis D.G., Papadopoulos C.C., and Hearse D.J. Multiple cycles of preconditioning cause loss of protection in open-chest rabbits. J Mol Cell Cardiol 29 (1997) 915-920
14. Kremastinos DTh., Bofilis E., Karavolias G., Papalois A., Kaklamanis L., and Iliodromitis E. Preconditioning limits myocardial infarct size in hypocholesterolemic rabbits. Atherosclerosis 150 (2000) 81-89
15. Sack S., Mohri M., Arras M., Schwarz E.R., and Shaper W. Ischemic preconditioning-time course of renewal in the pig. Cardiovasc Res 27 (1993) 551-555
16. Murphy E., Glaskow W., Fralix T., and Steenbergen C. Role of lipoxygenase metabolites in ischemic preconditioning. Circ Res 76 (1995) 457-467
17. Goto M., Liu Y., Yang X.M., Ardell J.L., Cohen M.V., and Downey J.M. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77 (1995) 611-621
18. Bolli R., Zughaib M., Li X.Y., Tang X.L., Sun J.Z., Triana J.F., et al. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial stunning. J Clin Invest 96 (1995) 1066-1084
19. 2+ ATPase downregulation after myocardial infarction. Free Radic Biol Med 40 (2006) 1827-1842
20. Post H., Schulz R., Behrends M., Gres P., Unschlag C., and Heusch G. No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine. J Mol Cell Cardiol 32 (2000) 725-733
21. Valhaus C., Schulz R., Post H., Rose J., and Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol 30 (1998) 197-209
22. Janssen M., van der Meer P., and de Jong J.W. Antioxidant defences in rat, pig, guinea pig and human hearts. Comparison with xanthine-oxidoreductase activity. Cardiovasc Res 27 (1993) 2052-2057
23. de Jong J.W., van der Meer P., Nieukoop A.S., Huizer T., Stroeva R.J., and Bos E. Xanthine oxidoreductase activity in perfused hearts in various species including humans. Circ Res 67 (1990) 770-773
24. Miki T., Cohen M.V., and Downey J. Failure of N-2-mercaptopropionyl glycine to reduce myocardial infarction after 3 days of reperfusion in rabbits. Basic Res Cardiol 94 (1999) 180-187
25. Bellows S., Hale S.L., Simklovich B.Z., Kay G.L., and Kloner R.A. Do antioxidant vitamins reduce infarct size following acute myocardial ischemia reperfusion?. Cardiovasc Drugs Ther 9 (1995) 117-123
26. Klein H., Pich S., Lindert S., Nebendahl K., Niedmann P., and Kreuzer H. Combined treatment with vitamins E and C in experimental myocardial infarction in pigs. Am Heart J 118 (1989) 667-673
27. Campo G.M., Squadrito F., Campo S., Altavilla D., Quartarone C., Ceccarelli S., et al. Beneficial effect of raxofelast, a hydrophilic vitamin E analogue, in the rat heart after ischemia and reperfusion injury. J Mol Cell Cardiol 30 (1998) 1493-1503
28. 4 poisoning?. Free Radic Biol Med 38 (2005) 698-710
29. 4 poisoning. Free Radic Biol Med 38 (2005) 711-718
30. Guaiquil V.H., Golde D.W., Beckles D.L., Mascareno E.J., and Siddiqui M.A.Q. Vitamin C inhibits hypoxia-induced damage and apoptotic signalling pathways in cardiomyocytes and ischemic hearts. Free Radic Biol Med 37 (2004) 1419-1429
31. Vergely C., Maupoil V., Benderitter M., and Rochette L. Influence of the severity of myocardial ischemia on the intensity of ascorbyl free radical release and on postischemic recovery during reperfusion. Free Radic Biol Med 24 (1998) 470-479
32. Sharma M.K., Buettner G.R., Spencer K.T., and Kerber R.E. Ascorbyl free radical as a real-time marker of free radical generation in briefly ischemic and reperfused hearts. An electron paramagnetic resonance study. Circ Res 74 (1994) 650-658
33. Pietri S., Seguin J.R., d'Arbigny P.D., and Culcasi M. Ascorbyl free radical: a non-invasive marker of oxidative stress in human open-heart surgery. Free Radic Biol Med 16 (1994) 523-528
34. Downey J.M., Davis A.M., and Cohen M.V. Signalling pathways in ischemic preconditioning. Heart Fail Rev 12 (2007) 181-188
35. Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med 222 (1999) 196-204
36. Casalino E., Sblanco C., and Landriscina C. A possible mechanism for initiation of lipid peroxidation by ascorbate in rat liver microsomes. Int J Biochem Cell Biol 28 (1996) 137-149
37. Feuerstein G.Z., and Young P.R. Apoptosis in cardiac diseases: stress- and mitogen-activated signalling pathways. Cardiovasc Res 45 (2000) 560-569
38. Iliodromitis E.K., Gaitanaki C., Lazou A., Bofilis E., Karavolias G.K., Beis I., et al. Dissociation of stress-activated protein kinase (p38-MAPK and JNKs) phosphorylation from the protective effect of preconditioning in vivo. J Mol Cell Cardiol 34 (2002) 1019-1028
39. Wei S., Rothstein E.C., Fliegel L., Dell'Italia L.J., and Lucchesi P.A. Differential MAP kinase activation and Na+/H+ exchanger phosphorylation by H(2)O(2) in rat cardiac myocytes. Am J Physiol Cell Physiol 281 (2001) C1542-C1550
40. Qin F., Shite J., and Liang C. Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways. Am J Physiol Heart Circ Physiol 285 (2003) H822-H832
41. Rebrin I., Zicker S., Wedekind K.J., Paetau-Robinson I., Packer L., and Sohal R.S. Effect of antioxidant-enriched diets on glutathione redox status in tissue homogenetaes and mitochondria of the senescence-accelerated mouse. Free Radic Biol Med 39 (2005) 549-557
42. Steeves G., Singh N., and Singal P.K. Preconditioning and antioxidant defense against reperfusion injury. Ann NY Acad Sci 723 (1994) 116-127